NCT02548780 2020-01-27
LifePearl-Doxo Pharmacokinetic (PK) Study
Terumo Europe N.V.
Phase NA Completed
Clinical Trials
3 trialsNCT00727233 2019-12-12
Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00323323 2017-01-20
CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas
Ohio State University Comprehensive Cancer Center
Phase 1 Completed